Skip to main content
The BMJ logoLink to The BMJ
. 1992 Sep 5;305(6853):567–574. doi: 10.1136/bmj.305.6853.567

Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

PMCID: PMC1883249  PMID: 1298229

Full text

PDF
567

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badaracco M. A., Vessey M. P. Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J. 1974 Feb 9;1(5901):215–217. doi: 10.1136/bmj.1.5901.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergentz S. E. Dextran in the prophylaxis of pulmonary embolism. World J Surg. 1978 Jan;2(1):19–25. doi: 10.1007/BF01574452. [DOI] [PubMed] [Google Scholar]
  3. Bergqvist D., Jendteg S., Lindgren B., Mätzsch T., Persson U. The economics of general thromboembolic prophylaxis. World J Surg. 1988 Jun;12(3):349–355. doi: 10.1007/BF01655669. [DOI] [PubMed] [Google Scholar]
  4. Bonnar J. Coagulation effects of oral contraception. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 2):1042–1048. doi: 10.1016/s0002-9378(87)80129-1. [DOI] [PubMed] [Google Scholar]
  5. Brenkel I. J., Clancy M. J. Total hip replacement and antithrombotic prophylaxis. Br J Hosp Med. 1989 Oct;42(4):282–284. [PubMed] [Google Scholar]
  6. Clagett G. P., Reisch J. S. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1988 Aug;208(2):227–240. doi: 10.1097/00000658-198808000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clark-Pearson D. L., DeLong E., Synan I. S., Soper J. T., Creasman W. T., Coleman R. E. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol. 1990 Apr;75(4):684–689. [PubMed] [Google Scholar]
  8. Colditz G. A., Tuden R. L., Oster G. Rates of venous thrombosis after general surgery: combined results of randomised clinical trials. Lancet. 1986 Jul 19;2(8499):143–146. doi: 10.1016/s0140-6736(86)91955-0. [DOI] [PubMed] [Google Scholar]
  9. Collins R., Scrimgeour A., Yusuf S., Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988 May 5;318(18):1162–1173. doi: 10.1056/NEJM198805053181805. [DOI] [PubMed] [Google Scholar]
  10. Conard J., Horellou M. H., Van Dreden P., Lecompte T., Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost. 1990 Apr 12;63(2):319–320. [PubMed] [Google Scholar]
  11. Cruickshank M. K., Levine M. N., Hirsh J., Turpie A. G., Powers P., Jay R., Gent M. An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgery. Thromb Haemost. 1989 Nov 24;62(3):830–834. [PubMed] [Google Scholar]
  12. Dale C., Gallus A., Wycherley A., Langlois S., Howie D. Prevention of venous thrombosis with minidose warfarin after joint replacement. BMJ. 1991 Jul 27;303(6796):224–224. doi: 10.1136/bmj.303.6796.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dechavanne M., Ville D., Berruyer M., Trepo F., Dalery F., Clermont N., Lerat J. L., Moyen B., Fischer L. P., Kher A. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis. 1989;19(1):5–12. doi: 10.1159/000215882. [DOI] [PubMed] [Google Scholar]
  14. Fordyce M. J., Baker A. S., Staddon G. E. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ. 1991 Jul 27;303(6796):219–220. doi: 10.1136/bmj.303.6796.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Francis C. W., Marder V. J., Evarts C. M., Yaukoolbodi S. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. JAMA. 1983 Jan 21;249(3):374–378. doi: 10.1001/jama.249.3.374. [DOI] [PubMed] [Google Scholar]
  16. Gallus A. S. Anticoagulants in the prevention of venous thromboembolism. Baillieres Clin Haematol. 1990 Jul;3(3):651–684. doi: 10.1016/s0950-3536(05)80023-x. [DOI] [PubMed] [Google Scholar]
  17. Ginsberg J. S., Hirsh J. Use of anticoagulants during pregnancy. Chest. 1989 Feb;95(2 Suppl):156S–160S. doi: 10.1378/chest.95.2_supplement.156s. [DOI] [PubMed] [Google Scholar]
  18. Gruber U. F., Saldeen T., Brokop T., Eklöf B., Eriksson I., Goldie I., Gran L., Hohl M., Jonsson T., Kristersson S. Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. Br Med J. 1980 Jan 12;280(6207):69–72. doi: 10.1136/bmj.280.6207.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guillebaud J. Surgery and the pill. Br Med J (Clin Res Ed) 1985 Aug 24;291(6494):498–499. doi: 10.1136/bmj.291.6494.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Halkin H., Goldberg J., Modan M., Modan B. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med. 1982 May;96(5):561–565. doi: 10.7326/0003-4819-96-5-561. [DOI] [PubMed] [Google Scholar]
  21. Hall J. G., Pauli R. M., Wilson K. M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980 Jan;68(1):122–140. doi: 10.1016/0002-9343(80)90181-3. [DOI] [PubMed] [Google Scholar]
  22. Hill N. C., Hill J. G., Sargent J. M., Taylor C. G., Bush P. V. Effect of low dose heparin on blood loss at caesarean section. Br Med J (Clin Res Ed) 1988 May 28;296(6635):1505–1506. doi: 10.1136/bmj.296.6635.1505-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hirsh J. Heparin. N Engl J Med. 1991 May 30;324(22):1565–1574. doi: 10.1056/NEJM199105303242206. [DOI] [PubMed] [Google Scholar]
  24. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991 Jun 27;324(26):1865–1875. doi: 10.1056/NEJM199106273242606. [DOI] [PubMed] [Google Scholar]
  25. Houghton G. R., Papadakis E. G., Rizza C. R. Changes in blood coagulation during total hip replacement. Lancet. 1978 Jun 24;1(8078):1336–1338. doi: 10.1016/s0140-6736(78)92406-6. [DOI] [PubMed] [Google Scholar]
  26. Howell R., Fidler J., Letsky E., de Swiet M. The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial. Br J Obstet Gynaecol. 1983 Dec;90(12):1124–1128. doi: 10.1111/j.1471-0528.1983.tb06458.x. [DOI] [PubMed] [Google Scholar]
  27. Hull R. D., Hirsh J., Sackett D. L., Stoddart G. L. Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J. 1982 Nov 15;127(10):990–995. [PMC free article] [PubMed] [Google Scholar]
  28. Hull R. D., Raskob G. E., Gent M., McLoughlin D., Julian D., Smith F. C., Dale N. I., Reed-Davis R., Lofthouse R. N., Anderson C. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA. 1990 May 2;263(17):2313–2317. [PubMed] [Google Scholar]
  29. Hull R., Delmore T. J., Hirsh J., Gent M., Armstrong P., Lofthouse R., MacMillan A., Blackstone I., Reed-Davis R., Detwiler R. C. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res. 1979;16(1-2):37–45. doi: 10.1016/0049-3848(79)90267-6. [DOI] [PubMed] [Google Scholar]
  30. Hutchison G. L. Oral contraception and post-operative thromboembolism: an epidemiological review. Scott Med J. 1989 Dec;34(6):547–549. doi: 10.1177/003693308903400601. [DOI] [PubMed] [Google Scholar]
  31. Kakkar V. V., Howe C. T., Nicolaides A. N., Renney J. T., Clarke M. B. Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg. 1970 Oct;120(4):527–530. doi: 10.1016/s0002-9610(70)80023-x. [DOI] [PubMed] [Google Scholar]
  32. Karwinski B., Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol. 1989 Feb;42(2):135–139. doi: 10.1136/jcp.42.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lao T. T., de Swiet M., Letsky S. E., Walters B. N. Prophylaxis of thromboembolism in pregnancy: an alternative. Br J Obstet Gynaecol. 1985 Mar;92(3):202–206. doi: 10.1111/j.1471-0528.1985.tb01082.x. [DOI] [PubMed] [Google Scholar]
  34. Laverick M. D., Croal S. A., Mollan R. A. Orthopaedic surgeons and thromboprophylaxis. BMJ. 1991 Sep 7;303(6802):549–550. doi: 10.1136/bmj.303.6802.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Levine M. N., Hirsh J. Clinical potential of low molecular weight heparins. Baillieres Clin Haematol. 1990 Jul;3(3):545–554. doi: 10.1016/s0950-3536(05)80018-6. [DOI] [PubMed] [Google Scholar]
  36. Levine M. N., Hirsh J., Gent M., Turpie A. G., Leclerc J., Powers P. J., Jay R. M., Neemeh J. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med. 1991 Apr 1;114(7):545–551. doi: 10.7326/0003-4819-114-7-545. [DOI] [PubMed] [Google Scholar]
  37. Leyvraz P. F., Bachmann F., Hoek J., Büller H. R., Postel M., Samama M., Vandenbroek M. D. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ. 1991 Sep 7;303(6802):543–548. doi: 10.1136/bmj.303.6802.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Leyvraz P. F., Richard J., Bachmann F., Van Melle G., Treyvaud J. M., Livio J. J., Candardjis G. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 1983 Oct 20;309(16):954–958. doi: 10.1056/NEJM198310203091605. [DOI] [PubMed] [Google Scholar]
  39. McCarthy S. T., Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing. 1986 Mar;15(2):84–88. doi: 10.1093/ageing/15.2.84. [DOI] [PubMed] [Google Scholar]
  40. Morris G. K., Mitchell J. R. Evaluation of 125I-fibrinogen test for venous thrombosis in patients with hip fractures: comparison between isotope scanning and necropsy findings. Br Med J. 1977 Jan 29;1(6056):264–266. doi: 10.1136/bmj.1.6056.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Morris G. K., Mitchell J. R. Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet. 1976 Oct 23;2(7991):869–872. doi: 10.1016/s0140-6736(76)90536-5. [DOI] [PubMed] [Google Scholar]
  42. Morris G. K. Prevention of venous thromboembolism. A survey of methods used by orthopaedic and general surgeons. Lancet. 1980 Sep 13;2(8194):572–574. doi: 10.1016/s0140-6736(80)92002-4. [DOI] [PubMed] [Google Scholar]
  43. Nurmohamed M. T., Rosendaal F. R., Büller H. R., Dekker E., Hommes D. W., Vandenbroucke J. P., Briët E. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet. 1992 Jul 18;340(8812):152–156. doi: 10.1016/0140-6736(92)93223-a. [DOI] [PubMed] [Google Scholar]
  44. Orme M. L., Lewis P. J., de Swiet M., Serlin M. J., Sibeon R., Baty J. D., Breckenridge A. M. May mothers given warfarin breast-feed their infants? Br Med J. 1977 Jun 18;1(6076):1564–1565. doi: 10.1136/bmj.1.6076.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Oster G., Tuden R. L., Colditz G. A. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. JAMA. 1987 Jan 9;257(2):203–208. [PubMed] [Google Scholar]
  46. Parker-Williams J., Vickers R. Major orthopaedic surgery on the leg and thromboembolism. BMJ. 1991 Sep 7;303(6802):531–532. doi: 10.1136/bmj.303.6802.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pezzuoli G., Neri Serneri G. G., Settembrini P., Coggi G., Olivari N., Buzzetti G., Chierichetti S., Scotti A., Scatigna M., Carnovali M. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group. Int Surg. 1989 Oct-Dec;74(4):205–210. [PubMed] [Google Scholar]
  48. Planes A., Vochelle N., Mazas F., Mansat C., Zucman J., Landais A., Pascariello J. C., Weill D., Butel J. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost. 1988 Dec 22;60(3):407–410. [PubMed] [Google Scholar]
  49. Planès A., Vochelle N., Fagola M., Feret J., Bellaud M. Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesia. J Bone Joint Surg Br. 1991 May;73(3):418–422. doi: 10.1302/0301-620X.73B3.1670442. [DOI] [PubMed] [Google Scholar]
  50. Poller L., McKernan A., Thomson J. M., Elstein M., Hirsch P. J., Jones J. B. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J (Clin Res Ed) 1987 Nov 21;295(6609):1309–1312. doi: 10.1136/bmj.295.6609.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Poller L., Taberner D. A., Sandilands D. G., Galasko C. S. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery. Thromb Haemost. 1982 Feb 26;47(1):50–53. [PubMed] [Google Scholar]
  52. Powers P. J., Gent M., Jay R. M., Julian D. H., Turpie A. G., Levine M., Hirsh J. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med. 1989 Apr;149(4):771–774. [PubMed] [Google Scholar]
  53. Prins M. H., Gelsema R., Sing A. K., van Heerde L. R., den Ottolander G. J. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis. 1989;19(5):245–250. doi: 10.1159/000215979. [DOI] [PubMed] [Google Scholar]
  54. Root H. D. Abdominal trauma and diagnostic peritoneal lavage revisited. Am J Surg. 1990 Apr;159(4):363–364. doi: 10.1016/s0002-9610(05)81271-1. [DOI] [PubMed] [Google Scholar]
  55. Rutherford S. E., Phelan J. P. Thromboembolic disease in pregnancy. Clin Perinatol. 1986 Dec;13(4):719–739. [PubMed] [Google Scholar]
  56. SEVITT S., GALLAGHER N. G. Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet. 1959 Dec 5;2(7110):981–989. doi: 10.1016/s0140-6736(59)91464-3. [DOI] [PubMed] [Google Scholar]
  57. Salzman E. W., Davies G. C. Prophylaxis of venous thromboembolism: analysis of cost effectiveness. Ann Surg. 1980 Feb;191(2):207–218. doi: 10.1097/00000658-198002000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Salzman E. W., Harris W. H. Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg Am. 1976 Oct;58(7):903–913. [PubMed] [Google Scholar]
  59. Sandler D. A., Martin J. F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989 Apr;82(4):203–205. doi: 10.1177/014107688908200407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Scurr J. H., Coleridge-Smith P. D., Hasty J. H. Deep venous thrombosis: a continuing problem. BMJ. 1988 Jul 2;297(6640):28–28. doi: 10.1136/bmj.297.6640.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Should the pill be stopped preoperatively? Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):786–787. doi: 10.1136/bmj.296.6624.786-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Stamatakis J. D., Kakkar V. V., Sagar S., Lawrence D., Nairn D., Bentley P. G. Femoral vein thrombosis and total hip replacement. Br Med J. 1977 Jul 23;2(6081):223–225. doi: 10.1136/bmj.2.6081.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Stevenson R. E., Burton O. M., Ferlauto G. J., Taylor H. A. Hazards of oral anticoagulants during pregnancy. JAMA. 1980 Apr 18;243(15):1549–1551. [PubMed] [Google Scholar]
  64. Stolley P. D., Tonascia J. A., Tockman M. S., Sartwell P. E., Rutledge A. H., Jacobs M. P. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol. 1975 Sep;102(3):197–208. doi: 10.1093/oxfordjournals.aje.a112148. [DOI] [PubMed] [Google Scholar]
  65. Sue-Ling H., Hughes L. E. Should the pill be stopped preoperatively? Br Med J (Clin Res Ed) 1988 Feb 13;296(6620):447–448. doi: 10.1136/bmj.296.6620.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Taberner D. A., Poller L., Burslem R. W., Jones J. B. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J. 1978 Feb 4;1(6108):272–274. doi: 10.1136/bmj.1.6108.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Taberner D. A., Poller L., Thomson J. M., Lemon G., Weighill F. J. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg. 1989 Sep;76(9):933–935. doi: 10.1002/bjs.1800760920. [DOI] [PubMed] [Google Scholar]
  68. Turpie A. G., Hirsh J., Gent M., Julian D., Johnson J. Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med. 1989 Mar;149(3):679–681. [PubMed] [Google Scholar]
  69. Turpie A. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Hull R. D., Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986 Oct 9;315(15):925–929. doi: 10.1056/NEJM198610093151503. [DOI] [PubMed] [Google Scholar]
  70. Turpie A. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Magnani H. N., Hull R. D., Gent M. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet. 1987 Mar 7;1(8532):523–526. doi: 10.1016/s0140-6736(87)90173-5. [DOI] [PubMed] [Google Scholar]
  71. Tørholm C., Broeng L., Jørgensen P. S., Bjerregaard P., Josephsen L., Jørgensen P. K., Hagen K., Knudsen J. B. Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled study. J Bone Joint Surg Br. 1991 May;73(3):434–438. doi: 10.1302/0301-620X.73B3.1670445. [DOI] [PubMed] [Google Scholar]
  72. Unreviewed reports. Br Med J (Clin Res Ed) 1985 Aug 24;291(6494):516–516. [PMC free article] [PubMed] [Google Scholar]
  73. Vessey M., Mant D., Smith A., Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):526–526. doi: 10.1136/bmj.292.6519.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Wildsmith J. A., McClure J. H. Anticoagulant drugs and central nerve blockade. Anaesthesia. 1991 Aug;46(8):613–614. doi: 10.1111/j.1365-2044.1991.tb09705.x. [DOI] [PubMed] [Google Scholar]
  75. Wille-Jørgensen P., Hauch O., Dimo B., Christensen S. W., Jensen R., Hansen B. Prophylaxis of deep venous thrombosis after acute abdominal operation. Surg Gynecol Obstet. 1991 Jan;172(1):44–48. [PubMed] [Google Scholar]
  76. de Swiet M., Floyd E., Letsky E. Low risk of recurrent thromboembolism in pregnancy. Br J Hosp Med. 1987 Sep;38(3):264–264. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES